Pharmacological effects of Astragaloside IV: a literature review

Journal of Traditional Chinese Medicine

Volumn 33, Issue 3, 2013, Pages 413-416

  Ren, Shuang ^a   Zhang, Hua ^a   Mu, Yongping ^a   Sun, Mingyu ^a   Liu, Ping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Astragaloside IV; Extraction; Pharmacokinetics; Pharmacology

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ASTRAGALOSIDE IV; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; BLOOD VESSEL FUNCTION; CALCIUM BALANCE; CELL PROLIFERATION; CHINESE MEDICINE; COLLAGEN METABOLISM; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; HEART FUNCTION; HEART PROTECTION; HUMAN; IMMUNITY; LIVER PROTECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLIC SYNDROME X; NEOPLASM; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; STOMACH PROTECTION; UMBILICAL VEIN ENDOTHELIAL CELL; VIRUS MYOCARDITIS;

EID: 84880454418     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60189-2     Document Type: Article

References (38)

1. State Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. 2005 edition. Beijing: Chemical Industry Press, 2005: 212-212.
2. Sun X Y, Sun F Y. Shen Nong Ben Cao Jing. Taiyuan: Shanxi Science and Technology Press, 2010: 112-113.
3. Huang H P, Liu C X, Li Y L, et al. Study on absorption kinetics of Astragaloside IV in rats intestines. Zhong Guo Zhong Yao Za Zhi 2008; 33(13): 1609-1611.
4. Zhang Q, Zhu L L, Chen G G, et al. Pharmacokinetics of Astragaloside iv in beagle dogs. Eur J Drug Metab Pharmacokinet 2007; 32(2): 75-79.
5. Huang C R, Wang G J, Wu X L, et al. Absorption enhancement study of Astragaloside IV based on its transport mechanism in Caco-2 cells. Eur J Drug Metab Pharmacokinet 2006; 31(1): 5-10.
6. Hu J Y, Han J, Chu Z G, et al. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Clin Exp Pharmacol Physiol 2009; 36(4): 351-357.
7. Li Z P, Cao Q. Effects of Astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol Sin 2002; 23(10): 898-904.
8. 1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol 2011; 658(2-3): 168-174.
9. Zhang Z C. Effect of Astragaloside on fibrosis in viral myocardial myocarditic mice. Chin J New drug Clin Rem 2003; 22(9): 515-519.
10. Li L, Tao H Y, Chen J B. Anti-apoptosis effect of Astragaloside on adriamycin induced rats cardiotoxicity. Chin J Integr Med 2006; 26(11): 1011-1014.
11. Zhang L, Liu Q, Lu L, et al. Astragaloside IV stimulates angiogenesis and increases HIF-1α accumulation via PI3K/Akt pathway. J Pharmacol Exp Ther 2011; 338(2): 485-491.
12. Zhang Y, Hu G, Li S, et al. Pro-angiogenic activity of Astragaloside IV in HUVECs in vitro and zebrafish in vivo. Mol Med Report 2012; 5(3): 805-811.
13. Ji K T, Tang J F, Chai J D, et al. Effect of Astragaloside against the oxidative damage on endothelial cells. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2011; 31(6): 807-810.
14. Li H B, Gei Y K, Zhang L, et al. Astragaloside IV improved barrier dysfunction induced by acute high glucose in human umbiIical vein endothehal cells. Life Sci 2006; 79(12): 1186-1193.
15. Liu X, Min W. Protective effects of Astragaloside against ultraviolet a-induced photoaging in human fibroblasts. Zhong Xi Yi Jie He Xue Bao 2011; 9(3): 328-332.
16. Wang X. Effects of Astragaloside on growth activity and apoptosis of fibroblasts from human skin with and without wrinkle in vitro. Chin J Med Aesthetics Cosmetol 2006; 12(2): 94-97.
17. Meng L Q, Tang J W, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. Br J Pharmacol 2011; 162(8): 1805-1818.
18. Liu H, Wei W, Sun W Y, et al. Protective effects of Astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J Ethnopharmacol 2009; 122(3): 502-508.
19. Zhang Z C, Li S J, Yang Y Z. Effect of Astragaloside on myocardial fibrosis in chronic myocarditis. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2007; 27(8): 728-731.
20. Li Z P. Dosage and time effects of astragaloside IV on myocardial collagen and function of ischemie rats. Chin J Clin Rehabil 2005; 9(23): 207-209.
21. Cheng M X, Chen Z Z, Cai Y L, et al. Astragaloside IV protects against ischemia reperfusion in a murine model of orthotopic liver transplantation. Transplant Proc 2011; 43(5): 1456-1461.
22. Wang S, Li J, Huang H, et al. Anti-hepatitis B virus activities of Astragaloside IV isolated from radix Astragali. Biol Pharm Bull 2009; 32(1): 132-135.
23. Zhang N, Wang X H, Mao S L, et al. Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats. Molecules 2011; 16(5): 3896-3907.
24. Lv L, Wu S Y, Wang G F, et al. Effect of Astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother Res 2010; 24(2): 219-224.
25. Zhu Z H, Wan H T, Li J H. Chuanxiongzine-astragaloside IV decreases IL-1β and Caspase-3 gene expressions in rat brain damaged by cerebral ischemia/reperfusion: A study of real-time quantitative PCR assay. Sheng Li Xue Bao 2011; 63(3): 272-280.
26. Luo Y, Hong Z. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 2004; 363(3): 218-223.
27. Li M, Qu Y Z, Zhao Z W, et al. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int 2012; 60(5): 458-465.
28. Chan W S, Durairajan S S, Lu J H, et al. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochem Int 2009; 55(6): 414-422.
29. Cheng C Y, Yao C H, Liu B S, et al. The role of Astragaloside in regeneration of the periphend nervesystem. J Biomed Mater Res A 2006; 76(3): 463-469.
30. Li Y R, Cao W, Guo J, et al. Comparative investigations on the protective effects of rhodioside, ciwujianoside-B and Astragaloside IV on radiation injuries of the hematopoietic system in mice. Phytother Res 2011; 25(5): 644-653.
31. Tan Y F, Yin X C, Xiong Y J, et al. Stem cell factor secretion by bone mesenchymal stem cells stimulated with Astragaloside IV. Zhong Guo Dang Dai Er Ke Za Zhi 2010; 12(4): 290-292.
32. Hong F, Xiao W, Ragupathi G, et al. The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines. Planta Med 2011; 77(8): 817-824.
33. Lin L, Shen H, Wang L X, et al. Effect of Astragaloside and β-elemene on the immune function of dendritic cells in mice. Southeast University: Medical Sciences 2011; 30(2): 294-297.
34. Yuan X, Sun S, Wang S, et al. Effects of Astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma. Planta Med 2011; 77(4): 328-333.
35. 1 and thymic stromal lymphopoietin in a murine model of asthma. Zhong Hua Yi Xue Za Zhi 2011; 91(44): 3139-3142.
36. Qi H, Wei L, Han Y, et al. Proteomic characterization of the cellular response to chemopreventive triterpenoid Astragaloside IV in human hepatocellular carcinoma cell line HepG2. Int J Oncol 2010; 36(3): 725-735.
37. Tian Y Z, Miao Q W, Zhao H L, et al. Effect of Astragaloside IV on reversal of multidrug resistance in hepatoma cell line HepG2/GCS. Drugs and clinical 2011; 7(11): 778-779.
38. Deng Y, Chen H F. Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines. Zhong Xi Yi Jie He Xue Bao 2009; 7(12): 1174-1180.